Clinical Trials on Hormone-sensitive Metastatic Breast Cancer
Total 22036 results
-
University of Alabama at BirminghamNot yet recruitingMetastatic Breast CancerUnited States
-
Jacinto Convit World Organization Inc.Instituto Oncologico Luis Razetti; Fundación Jacinto ConvitNot yet recruitingMetastatic Breast CancerUnited States, Venezuela
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
Power Life Sciences Inc.Not yet recruitingMetastatic Breast Cancer
-
Sermonix Pharmaceuticals Inc.RecruitingMetastatic Breast CancerUnited States, France, Belgium, Spain, Israel, Taiwan, United Kingdom, Korea, Republic of, Italy, Australia, Germany, Canada, Czechia, Hungary, Poland, Romania, Singapore, Turkey
-
German Cancer Research CenterUniversity Hospital HeidelbergRecruitingMetastatic Breast CancerGermany
-
Stemline Therapeutics, Inc.RecruitingMetastatic Breast CancerUnited States, Georgia, Brazil, Bulgaria, Romania
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
SOLTI Breast Cancer Research GroupNovartis; Alliance Foundation Trials, LLC.RecruitingMetastatic Breast CancerUnited States, Spain, Portugal
-
Novartis PharmaceuticalsRecruitingMetastatic Breast CancerUnited States, Lebanon, Hong Kong, Turkey, Vietnam, Brazil, Italy, South Africa, Korea, Republic of, Poland, Taiwan, Singapore, Japan, Spain, Costa Rica, Greece, Portugal, Argentina, Mexico
-
Asociatia Oncohelp - Centrul de Oncologie OncohelpMDX ResearchRecruitingMetastatic Breast CancerRomania
-
Herui YaoRecruiting
-
Hellenic Society of Medical OncologyRecruitingMetastatic Breast CancerGreece
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast Cancer | Breast Cancer MetastaticUnited States
-
German Breast GroupPfizer; AMS Advanced Medical Services GmbHRecruitingMetastatic Breast CancerGermany
-
Hamdy A. AzimRecruitingPalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer (FATIMA)Metastatic Breast CancerSouth Africa
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Sermonix Pharmaceuticals Inc.Active, not recruitingMetastatic Breast CancerUnited States
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
MedSIRGlaxoSmithKlineCompletedBreast Cancer | Breast Cancer MetastaticSpain
-
Sidney Kimmel Comprehensive Cancer Center at Johns...PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Breast CancerUnited States
-
Institut CurieTerminated
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Dana-Farber Cancer InstituteActive, not recruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Translational Drug DevelopmentSide-Out FoundationCompletedMetastatic Breast CancerUnited States
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
US Oncology ResearchBristol-Myers Squibb; PfizerActive, not recruiting
-
PfizerActive, not recruiting
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
Turkish Oncology GroupIstanbul University; Marmara University Pendik Training and Research Hospital; V.K.V. American Hospital, Istanbul and other collaboratorsCompletedMetastatic Breast CancerTurkey
-
Fudan UniversityActive, not recruitingMetastatic Breast CancerChina
-
AstraZenecaParexelCompletedMetastatic Breast CancerTaiwan, Hong Kong, Australia, Singapore, Korea, Republic of, Brazil
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
University of VirginiaSyndax PharmaceuticalsCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaNovartis PharmaceuticalsCompletedMetastatic Breast CancerAustralia
-
German Breast GroupCompletedMetastatic Breast CancerGermany
-
Sun Yat-sen UniversityCompletedBreast Cancer MetastaticChina
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Hager salah el dinCompletedMetastatic Breast CancerEgypt
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...